Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair Response

Cell Stem Cell. 2020 Dec 3;27(6):869-875.e4. doi: 10.1016/j.stem.2020.11.010. Epub 2020 Nov 17.

Abstract

Current smoking is associated with increased risk of severe COVID-19, but it is not clear how cigarette smoke (CS) exposure affects SARS-CoV-2 airway cell infection. We directly exposed air-liquid interface (ALI) cultures derived from primary human nonsmoker airway basal stem cells (ABSCs) to short term CS and then infected them with SARS-CoV-2. We found an increase in the number of infected airway cells after CS exposure with a lack of ABSC proliferation. Single-cell profiling of the cultures showed that the normal interferon response was reduced after CS exposure with infection. Treatment of CS-exposed ALI cultures with interferon β-1 abrogated the viral infection, suggesting one potential mechanism for more severe viral infection. Our data show that acute CS exposure allows for more severe airway epithelial disease from SARS-CoV-2 by reducing the innate immune response and ABSC proliferation and has implications for disease spread and severity in people exposed to CS.

Keywords: COVID-19; airway basal stem cells; cigarette smoke; injury and repair; interferon response; mucociliary clearance; single cell RNA sequencing; viral infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / genetics
  • COVID-19 / immunology
  • COVID-19 / physiopathology*
  • COVID-19 / therapy
  • Cells, Cultured
  • Down-Regulation
  • Humans
  • Immunity, Innate
  • Interferon-beta / therapeutic use
  • Patient Acuity
  • Respiratory Mucosa / physiopathology*
  • Respiratory Mucosa / virology
  • Smoking / adverse effects*
  • Stem Cells / virology*

Substances

  • Interferon-beta